List of Excipients in API prademagene zamikeracel
✉ Email this page to a colleague
Detailed excipient profiles for prademagene zamikeracel
Excipient focus: 2-AMINOETHANOL
prademagene zamikeracel drug variants containing 2-AMINOETHANOL
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing 2-AMINOETHANOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ADENINE HYDROCHLORIDE
prademagene zamikeracel drug variants containing ADENINE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing ADENINE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ALANINE
prademagene zamikeracel drug variants containing ALANINE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing ALANINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIUM METAVANADATE
prademagene zamikeracel drug variants containing AMMONIUM METAVANADATE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing AMMONIUM METAVANADATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: AMMONIUM MOLYBDATE
prademagene zamikeracel drug variants containing AMMONIUM MOLYBDATE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing AMMONIUM MOLYBDATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS DEXTROSE
prademagene zamikeracel drug variants containing ANHYDROUS DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing ANHYDROUS DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ARGININE HYDROCHLORIDE
prademagene zamikeracel drug variants containing ARGININE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing ARGININE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ARLIPOIC ACID
prademagene zamikeracel drug variants containing ARLIPOIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing ARLIPOIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ASPARAGINE MONOHYDRATE
prademagene zamikeracel drug variants containing ASPARAGINE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing ASPARAGINE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ASPARTIC ACID
prademagene zamikeracel drug variants containing ASPARTIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing ASPARTIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BIOTIN
prademagene zamikeracel drug variants containing BIOTIN
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing BIOTIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BOS TAURUS PITUITARY GLAND
prademagene zamikeracel drug variants containing BOS TAURUS PITUITARY GLAND
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing BOS TAURUS PITUITARY GLAND
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BOVINE TRANSFERRIN
prademagene zamikeracel drug variants containing BOVINE TRANSFERRIN
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing BOVINE TRANSFERRIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CALCIUM CHLORIDE
prademagene zamikeracel drug variants containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing CALCIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CHOLINE CHLORIDE
prademagene zamikeracel drug variants containing CHOLINE CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing CHOLINE CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CUPRIC SULFATE
prademagene zamikeracel drug variants containing CUPRIC SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing CUPRIC SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CYANOCOBALAMIN
prademagene zamikeracel drug variants containing CYANOCOBALAMIN
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing CYANOCOBALAMIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CYSTEINE
prademagene zamikeracel drug variants containing CYSTEINE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing CYSTEINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC SULFATE
prademagene zamikeracel drug variants containing FERRIC SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing FERRIC SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROUS SULFATE
prademagene zamikeracel drug variants containing FERROUS SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing FERROUS SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FOLIC ACID
prademagene zamikeracel drug variants containing FOLIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing FOLIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLUTAMIC ACID
prademagene zamikeracel drug variants containing GLUTAMIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing GLUTAMIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLUTAMINE
prademagene zamikeracel drug variants containing GLUTAMINE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing GLUTAMINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCINE
prademagene zamikeracel drug variants containing GLYCINE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing GLYCINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HISTIDINE MONOHYDROCHLORIDE
prademagene zamikeracel drug variants containing HISTIDINE MONOHYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing HISTIDINE MONOHYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HUMAN EPIDERMAL GROWTH FACTOR
prademagene zamikeracel drug variants containing HUMAN EPIDERMAL GROWTH FACTOR
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing HUMAN EPIDERMAL GROWTH FACTOR
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HUMAN TRANSFERRIN HOLO
prademagene zamikeracel drug variants containing HUMAN TRANSFERRIN HOLO
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing HUMAN TRANSFERRIN HOLO
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
prademagene zamikeracel drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROCORTISONE
prademagene zamikeracel drug variants containing HYDROCORTISONE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing HYDROCORTISONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID
prademagene zamikeracel drug variants containing HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: INOSITOL
prademagene zamikeracel drug variants containing INOSITOL
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing INOSITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: INSULIN HUMAN
prademagene zamikeracel drug variants containing INSULIN HUMAN
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing INSULIN HUMAN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOLEUCINE
prademagene zamikeracel drug variants containing ISOLEUCINE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing ISOLEUCINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LEUCINE
prademagene zamikeracel drug variants containing LEUCINE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing LEUCINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LIOTHYRONINE
prademagene zamikeracel drug variants containing LIOTHYRONINE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing LIOTHYRONINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LYSINE HYDROCHLORIDE
prademagene zamikeracel drug variants containing LYSINE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing LYSINE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM CHLORIDE
prademagene zamikeracel drug variants containing MAGNESIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing MAGNESIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MANGANESE SULFATE
prademagene zamikeracel drug variants containing MANGANESE SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing MANGANESE SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MECASERMIN
prademagene zamikeracel drug variants containing MECASERMIN
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing MECASERMIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHIONINE
prademagene zamikeracel drug variants containing METHIONINE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing METHIONINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: NIACINAMIDE
prademagene zamikeracel drug variants containing NIACINAMIDE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing NIACINAMIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: NICKEL CHLORIDE
prademagene zamikeracel drug variants containing NICKEL CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing NICKEL CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: NICKEL SULFATE HEPTAHYDRATE
prademagene zamikeracel drug variants containing NICKEL SULFATE HEPTAHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing NICKEL SULFATE HEPTAHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PANTOTHENIC ACID
prademagene zamikeracel drug variants containing PANTOTHENIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing PANTOTHENIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PHENOLSULFONPHTHALEIN
prademagene zamikeracel drug variants containing PHENOLSULFONPHTHALEIN
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing PHENOLSULFONPHTHALEIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PHENYLALANINE
prademagene zamikeracel drug variants containing PHENYLALANINE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing PHENYLALANINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PHOSPHORYLCOLAMINE
prademagene zamikeracel drug variants containing PHOSPHORYLCOLAMINE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing PHOSPHORYLCOLAMINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
prademagene zamikeracel drug variants containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROLINE
prademagene zamikeracel drug variants containing PROLINE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing PROLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PUTRESCINE DIHYDROCHLORIDE
prademagene zamikeracel drug variants containing PUTRESCINE DIHYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing PUTRESCINE DIHYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PYRIDOXAL HYDROCHLORIDE
prademagene zamikeracel drug variants containing PYRIDOXAL HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing PYRIDOXAL HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PYRIDOXINE HYDROCHLORIDE
prademagene zamikeracel drug variants containing PYRIDOXINE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing PYRIDOXINE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: RIBOFLAVIN
prademagene zamikeracel drug variants containing RIBOFLAVIN
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing RIBOFLAVIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SERINE
prademagene zamikeracel drug variants containing SERINE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing SERINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE
prademagene zamikeracel drug variants containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing SODIUM ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM BICARBONATE
prademagene zamikeracel drug variants containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing SODIUM BICARBONATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
prademagene zamikeracel drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM METASILICATE
prademagene zamikeracel drug variants containing SODIUM METASILICATE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing SODIUM METASILICATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
prademagene zamikeracel drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PYRUVATE
prademagene zamikeracel drug variants containing SODIUM PYRUVATE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing SODIUM PYRUVATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM SELENITE
prademagene zamikeracel drug variants containing SODIUM SELENITE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing SODIUM SELENITE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM SULFATE ANHYDROUS
prademagene zamikeracel drug variants containing SODIUM SULFATE ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing SODIUM SULFATE ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STANNOUS CHLORIDE
prademagene zamikeracel drug variants containing STANNOUS CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing STANNOUS CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: THIAMINE HYDROCHLORIDE
prademagene zamikeracel drug variants containing THIAMINE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing THIAMINE HYDROCHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: THREONINE
prademagene zamikeracel drug variants containing THREONINE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing THREONINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: THYMIDINE
prademagene zamikeracel drug variants containing THYMIDINE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing THYMIDINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRYPTOPHAN
prademagene zamikeracel drug variants containing TRYPTOPHAN
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing TRYPTOPHAN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TYROSINE
prademagene zamikeracel drug variants containing TYROSINE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing TYROSINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: VALINE
prademagene zamikeracel drug variants containing VALINE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing VALINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ZINC SULFATE HEPTAHYDRATE
prademagene zamikeracel drug variants containing ZINC SULFATE HEPTAHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Abeona Therapeutics Inc | prademagene zamikeracel | 84103-007 |
| >Company | >Ingredient | >NDC |
prademagene zamikeracel drug variants not containing ZINC SULFATE HEPTAHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links